Sarcomatoid mesothelioma is a rare and aggressive form of cancer that affects the thin layer of cells that line the body’s internal organs and cavities, known as the mesothelium. This type of cancer is caused by exposure to asbestos, and it is most common in people over the age of 55. Although sarcomatoid mesothelioma is a rare type of cancer, it is important to understand the risks and prognosis of this disease.
The risk of developing sarcomatoid mesothelioma increases with age and the amount of time someone is exposed to asbestos. This means that people who work in industries that involve asbestos, such as the construction and shipbuilding industries, are at greater risk of developing this disease. People who live near asbestos mines or in areas where asbestos is present in the environment are also more likely to develop this cancer.
Once someone is diagnosed with sarcomatoid mesothelioma, the prognosis is usually very poor. This is because the cancer is usually very advanced when it is diagnosed, and it is very difficult to treat. Most people with this type of cancer live for less than a year after diagnosis, and the average survival time is less than six months.
Treatment options for sarcomatoid mesothelioma are limited, but some people may benefit from surgery, chemotherapy, or radiation therapy. Surgery can be used to remove tumors, but it is not always possible due to the location and size of the tumors. Chemotherapy and radiation therapy can help to shrink tumors and prolong life, but these treatments can also have serious side effects.
It is important to understand the risks and prognosis of sarcomatoid mesothelioma. This rare and aggressive cancer is caused by exposure to asbestos, and it is most common in people over the age of 55. The prognosis of this disease is usually very poor, with the average survival time being less than six months. Treatment options are limited, but some people may benefit from surgery, chemotherapy, or radiation therapy.